Lok Sabha Confirms Imposition of President Rule in Manipur  ||  AP HC: Court Possesses Limited Scope of Judicial Review in Transfer Cases on Account of Exigencies  ||  Bom. HC: Can’t Evict Tenants Under Arbitration Act if Occupying Premises Falling under DA  ||  Delhi High Court Passes Permanent Injunction in Favour of ‘Peak XV Partners’  ||  Bombay HC: Condition that Younger Candidate Would be Preferred Over Older Candidate Violates COI  ||  Kar. HC Refuses to Entertain Petition Seeking Implementation of Circular Regarding Usage of ‘Dalit’  ||  Kar. HC: Rapido, Uber Can’t Operate in State Unless Relevant Guidelines Issued  ||  Delhi HC: Preserve CCTV Footage When Complaint against Dept. Regarding Illegal Detention in Received  ||  SC Refuses to Direct States to Establish Public Libraries  ||  SC: To Prevent Re-Litigation, Quasi-Judicial Bodies are Bound by Principles of Res-Judicata    

SEBI Imposes Rs. 22 Crore fine on Aurobindo Pharma for Insider Trading - (24 Sep 2019)

CAPITAL MARKET

Securities and Exchange Board of India has imposed a fine of Rs. 22.7 crore on Aurobindo Pharma Ltd., its promoters and related entities for insider trading between July, 2008 to March, 2009.

Tags : SECURITIES AND EXCHANGE BOARD OF INDIA   AUROBINDO PHARMA LTD.  SEBI  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved